Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GAT@F nanoenzyme hydrogel for diabetic wounds
NCT06492811Phase 2Active, not recruiting
- Sponsor
- The First Affiliated Hospital of the University of South China
- Start
- Apr 2024
- Primary completion
- Feb 2025
- Modality
- Hydrogel Systems, Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of GAT@F in diabetic foot ulcer (DFU), sponsored by The First Affiliated Hospital of the University of South China. Started Apr 2024; status: active, not recruiting.
02
Drugs
GAT@F
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT06492811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06492811.